Article thumbnail
Location of Repository

Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think?

By Nicola Steele, Rachel Haigh, Gillian Knowles and Melanie Mackean

Abstract

The carcinoembryonic antigen (CEA) blood test is included in most colorectal cancer follow up protocols, despite little clear evidence for its cost‐effectiveness and survival benefit. In this study, patients' views were sought on the use of the CEA blood test in their follow up. Strong associations were found between the age of a patient's children and their concern about cancer recurrence and between concern about recurrence and anxiety about CEA test results (p<0.0001). Many patients expressed a desire for prognostic information, however uncertain or poor. Patients' views should be sought when designing colorectal cancer follow up protocols to ensure their needs are adequately addressed

Topics: Short Report
Publisher: BMJ Group
OAI identifier: oai:pubmedcentral.nih.gov:2600007
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.